Recruiting studies: Embolic Stroke Of Undetermined Source

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients wit
Phase 2/Phase 3 · 1 location(s) · University of East Anglia · NCT06715449 High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Di
Phase N/A · 1 location(s) · Acandis GmbH · NCT07166731 Left Atrial Strain and Cryptogenic Stroke
Phase N/A · 1 location(s) · University of Pittsburgh · NCT07224178 Echocardiographic Predictors of Atrial Fibrillation
Phase N/A · 1 location(s) · Karl Landsteiner University of Health Sciences · NCT05044208 Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study
Phase N/A · 3 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06100718 AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM
Phase N/A · 5 location(s) · Inha University Hospital · NCT07347691 SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation
Phase N/A · 3 location(s) · Taichung Veterans General Hospital · NCT07479147 Prospective Registry of Elderly ESUS With PFO
Phase N/A · 1 location(s) · Asan Medical Center · NCT05238610 Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause
NA · 1 location(s) · Asan Medical Center · NCT07295769

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.